Day: February 20, 2025

On 20 February 2025, AS Tallink Grupp held an investor webinar where Paavo Nõgene, the Chairman of the Management Board, and Harri Hanschmidt and Margus Schults, the members of the Management Board introduced the results of the fourth quarter and 12 months of 2024. AS Tallink Grupp would like to thank all the participants. The webinar presentation is enclosed and the webinar recording is available at Reports & Financial key figures. Anneli Simm Investor Relations Manager AS Tallink Grupp Sadama 5 10111 Tallinn, Estonia E-mail: anneli.simm@tallink.ee Phone: +372 56157170AttachmentAS Tallink Grupp Q4 2024 Webinar Presentation

MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces its financial results for the year ended 31 December 2024. All figures are in AU$ unless stated otherwise. FY2024 highlightsTotal revenue, driven primarily from sales of Illuccix® of $783.2 million, up by 56%1 from $502.5 million in 2023, beating full year guidance2. Second year of profitable growth, delivered in a period of investment, including:R&D investment of $194.6 million, in line with guidance, with a focus on late-stage assets. Expanded global supply chain and product delivery infrastructure, including acquisitions of ARTMS, Inc. and IsoTherapeutics Group, LLC, and expansion of Telix Manufacturing Solutions’ Brussels South facility, resulting in an incremental...

CALGARY, Alberta, Feb. 20, 2025 (GLOBE NEWSWIRE) — TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today reported its financial results for the fourth quarter and year ended Dec. 31, 2024. “Our business delivered solid results within the upper range of our guidance, driven by high availability across our generation portfolio, along with the enduring performance of our optimization and hedging strategies. During the year, we added 2.2 GW of generation to our fleet, with three contracted wind facilities achieving commercial operation in addition to the acquisition of Heartland Generation. We also returned $214 million, or $0.71 per share, of value to shareholders through dividends and share repurchases at an average price of $10.59 per share,” said John Kousinioris, President and Chief Executive Officer of...

– Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively – – Received FDA approval of GOMEKLI™ (mirdametinib) for the treatment of adult and pediatric patients with symptomatic NF1-PN not amendable to complete resection – – Ended 2024 with $461.9 million in cash, cash equivalents and marketable securities – STAMFORD, Conn., Feb. 20, 2025 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today reported financial results for the fourth quarter and full year periods ended December 31, 2024 and provided an update on recent company developments. “We are very pleased with the strong execution of OGSIVEO in 2024 and believe that we are still...

ATLANTA, Feb. 20, 2025 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 13, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13750192. The replay will be available until March 20, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor...

Significant Margin Improvement & Strong Cash Generation Provides Full Year 2025 Outlook and Updates 2027 Targets BEDMINSTER, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) — Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Compared to Prior Year PeriodNet sales of $262.7 million, an increase of 22.0%. Net income of $18.1 million, compared to the prior year period of $15.3 million. Gross margin of 42.5%, compared to the prior year period of 34.6%. Adjusted Gross Margin of 48.1%, compared to the prior year period of 41.1%.1 Adjusted EBITDA of $52.6 million, compared to the prior year period of $31.3 million.1Full Year 2024 Financial Highlights Compared to Prior YearNet sales of $975.2...

MARIETTA, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) — Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) today reported its financial results for the fourth quarter and full year ended December 31, 2024. Significant items for fourth quarter of 2024 (all comparisons to fourth quarter of 2023):Net premiums earned increased 4.6% to $236.6 million Combined ratio of 92.9%, compared to 106.8% Net income of $24.0 million, or 70 cents per diluted Class A share, compared to net loss of $2.0 million, or 6 cents per Class A share Net investment gains (after tax) of $0.2 million, or 1 cent per diluted Class A share, compared to $1.8 million, or 5 cents per Class A share, are included in net income (loss)Significant items for full year of 2024 (all comparisons to full year of 2023):Net premiums earned increased 6.2% to $936.7 million Combined...

Fourth Quarter 2024 Financial HighlightsNet sales totaled $844 million, down 11% on a reported basis, down 10% at constant currency* Net income totaled $100 million; Net income margin 11.8% Adjusted EBITDA* totaled $153 million; Adjusted EBITDA margin* of 18.1% Net cash provided by operating activities totaled $131 million Adjusted free cash flow* totaled $157 millionFull Year 2024 Financial HighlightsNet sales totaled $3,475 million, down 11% on a reported basis, down 10% at constant currency* Net income totaled $282 million; Net income margin 8.1% Adjusted EBITDA* totaled $598 million; Adjusted EBITDA margin* of 17.2% Net cash provided by operating activities totaled $408 million Adjusted free cash flow* totaled $358 million Repurchased $296 million of common shares; 13% share reduction year-over-yearFull Year 2024 Business HighlightsContinuing...

CALGARY, Alberta, Feb. 20, 2025 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced its fourth-quarter and full-year 2024 financial and operating results. In the quarter, the company generated over $2.0 billion in cash from operating activities, $1.6 billion of adjusted funds flow and $123 million of free funds flow. The Upstream business continued to deliver strong performance, with production of 816,000 barrels of oil equivalent per day (BOE/d)1 in the quarter, including a new quarterly Oil Sands production record of 628,500 BOE/d. In the Downstream, total crude throughput increased by almost 24,000 barrels per day (bbls/d) from the previous quarter to 666,700 bbls/d, representing an aggregate utilization rate of 93%. HighlightsDelivered quarterly Upstream production of 816,000 BOE/d, an increase of...

HOUSTON, Feb. 20, 2025 (GLOBE NEWSWIRE) — Targa Resources Corp. (NYSE: TRGP) (“TRGP,” the “Company” or “Targa”) today reported fourth quarter and full year 2024 results. Fourth quarter 2024 net income attributable to Targa Resources Corp. was $351.0 million compared to $299.6 million for the fourth quarter of 2023. For the full year 2024, net income attributable to Targa Resources Corp. was $1,312.0 million compared to $1,345.9 million for 2023. The Company reported adjusted earnings before interest, income taxes, depreciation and amortization, and other non-cash items (“adjusted EBITDA”)(1) of $1,122.2 million for the fourth quarter of 2024 compared to $959.9 million for the fourth quarter of 2023. For the full year 2024, the Company reported adjusted EBITDA of $4,142.3 million compared to $3,530.0 million for 2023. HighlightsRecord...